Cardiac involvement by sarcoidosis and concomitant deposition of AL amyloid is an uncommon association. We describe the case of a 53-year-old African-American man with a 7-year history of dilated ...

NEW YORK CITY -- Patients with longstanding sarcoidosis and skin involvement had dramatic improvement after 6 months of treatment with the Janus kinase (JAK) inhibitor tofacitinib (Xeljanz), a small ...

Please provide your email address to receive an email when new articles are posted on . Electronic nose technology accurately distinguished patients with sarcoidosis from those with interstitial lung ...

The clinical implications of the diagnosis of sarcoidosis go well beyond the labeling of a syndrome. This is true not only because the etiology is yet to be determined but also because the clinical ...

IN 1941 Kveim 1 described a new skin reaction in which the intracutaneous injection of a homogenate of human sarcoidal tissue led to the formation of a nodule at the test site over the course of ...

FSR Awards Senthil Selvaraj, MD, MS, MA and Daniela Čiháková, MD, PhD, D(ABMLI) $100,000 in support of cardiac sarcoidosis. CHICAGO, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Foundation for Sarcoidosis ...

This is a preview. Log in through your library . Abstract Purpose Sarcoidosis is a multisystem disease that can negatively impact health-related quality of life (HRQL) across generic (e.g., physical, ...

Sarcoidosis is a condition involving the growth of persistent or inappropriate granulomas or clumps of inflammatory cells. For some people, symptoms will resolve on their own without needing treatment ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted fast-track designation for efzofitimod, a potential first-in-class immunomodulator, in the ...

A new study offers insight into a new treatment avenue for Crohn's Disease and sarcoidosis. While the loss of NOD2 increases the risk of developing Crohn's disease, increased activity of this gene is ...